Loading clinical trials...
Loading clinical trials...
An Open-label Dose-finding Study to Evaluate the Pharmacodynamic (PD) Profiles and Efficacy of Different Dosing Regimens of Leuprolide Oral Tablets (Ovarest®) in Women With Endometriosis
Conditions
Interventions
Leuprolide Oral Tablet - 120 mg - QD- Treatment A
Leuprolide Oral Tablet - 80 mg - QD - Treatment B
+3 more
Locations
4
United States
Physician Care Clinical Research, LLC
Sarasota, Florida, United States
Complete Healthcare for Women
Columbus, Ohio, United States
Tidewater Clinical Research
Norfolk, Virginia, United States
Seattle Clinical Research Center
Seattle, Washington, United States
Start Date
March 18, 2022
Primary Completion Date
May 1, 2022
Completion Date
May 1, 2022
Last Updated
March 22, 2022
NCT05951452
NCT06611501
NCT05726786
NCT07241637
NCT04567771
NCT07215130
Lead Sponsor
Enteris BioPharma Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions